Form 8-K - Current report:
SEC Accession No. 0001520138-25-000249
Filing Date
2025-08-11
Accepted
2025-08-11 16:25:18
Documents
18
Period of Report
2025-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20250807_8k.htm   iXBRL 8-K 36361
2 EXHIBIT 1.1 bivi-20250807_ex1z1.htm EX-1.1 402204
3 EXHIBIT 4.2 bivi-20250807_ex4z2.htm EX-4.2 99108
4 EXHIBIT 4.3 bivi-20250807_ex4z3.htm EX-4.3 115715
5 EXHIBIT 10.1 bivi-20250807_ex10z1.htm EX-10.1 258840
6 EXHIBIT 99.1 bivi-20250807_ex99z1.htm EX-99.1 11177
7 EXHIBIT 99.2 bivi-20250807_ex99z2.htm EX-99.2 10221
  Complete submission text file 0001520138-25-000249.txt   1334993

Data Files

Seq Description Document Type Size
8 XBRL LABEL FILE bivi-20250807_lab.xml EX-101.LAB 34235
9 XBRL PRESENTATION FILE bivi-20250807_pre.xml EX-101.PRE 22362
10 XBRL SCHEMA FILE bivi-20250807.xsd EX-101.SCH 3022
20 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20250807_8k_htm.xml XML 3568
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 251202373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)